Suppr超能文献

[下肢缺血的动脉内溶栓治疗]

[Intra-arterial thrombolytic therapy of lower limb ischemia].

作者信息

Juhan C, Haupert S, Miltgen G, Dulac P, Girard N, Barthélémy P, Raybaud C

机构信息

Centre hospitalier régional et universitaire de Marseille, Hôpital-Nord, Chemin des Bourrely.

出版信息

Bull Acad Natl Med. 1990 Feb;174(2):197-207; discussion 207-9.

PMID:2372717
Abstract

Between 1984 and 1989, 35 patients with recent arterial or graft occlusions have been treated with intra-arterial infusion using sequential association of Urokinase (U.K.) and Lys-Plasminogen. Occlusion was thrombotic in 68.5% of the cases ans embolic in 31.5%, involving 28 native arteries and 7 bypass grafts. The mean duration was 16 days (2 to 90). Continuous infusion of U.K.: 84,000 U.I./H and bolus of Lys-Plasminogen 15 microKatals every 30 minutes were delivered through a catheter embedded into the clot. Intra-venous heparin was always associated. The mean duration of lytic drug infusion was 8 H. Complementary arterial reconstruction by vascular surgery of percutaneous transluminal angioplasty was performed in 23% of the patients. Patients with recent alimentary tract bleeding, hemorragic stroke in the last six months or severe high blood pressures were contra-indicated. Complete lysis was obtained in 23 cases (66%), partial lysis in 7 (20%) and no lysis in 5 (14%). The clinical result was excellent in 24 cases (68.5%), good in 3 (8.5%) and bad in 8 (23%) in which amputation was always necessary. 5 local hematoma (14%) treated by surgery or transfusion and one death (3%) due to neurological complication occurring 24 hours after the end of the procedure were observed. The literature survey has shown that the results of low doses of Streptokinase (S.K.) local infusions were not better, and that higher doses of S.K. or U.K. delivered during a shorter infusion time increased the efficacy of lysis and decreased the rate of hemorragic complications. We have proposed the local thrombolytic treatment to the limb threatening ischemic cases when the traditional medical or surgical techniques where thought to be associated to a high risk of failure or complication. The specific indications are the acute or sub-acute ischemic situation due to atheromatous artery thrombosis, distal or old embolism where the Fogarty catheter is inefficient, and graft thrombosis. Severe acute ischemia with neurologic involvement are not good indications. Local thrombolysis can be successful on arterial occlusion even after one month duration.

摘要

1984年至1989年间,35例近期发生动脉或移植物闭塞的患者接受了动脉内输注治疗,采用尿激酶(U.K.)和赖氨酸纤溶酶原序贯联合用药。68.5%的病例闭塞为血栓形成,31.5%为栓塞,累及28条天然动脉和7条旁路移植物。平均病程为16天(2至90天)。通过埋入血栓的导管持续输注尿激酶:84,000 U.I./小时,每30分钟推注15微卡托的赖氨酸纤溶酶原。始终联合静脉注射肝素。溶栓药物输注的平均持续时间为8小时。23%的患者通过血管外科手术或经皮腔内血管成形术进行了补充动脉重建。近期有消化道出血、过去六个月内有出血性中风或严重高血压的患者为禁忌证。23例(66%)实现完全溶解,7例(20%)部分溶解,5例(14%)未溶解。24例(68.5%)临床结果极佳,3例(8.5%)良好,8例(23%)不佳,其中均需截肢。观察到5例局部血肿(14%)经手术或输血治疗,1例(3%)因术后24小时出现神经并发症死亡。文献调查表明,低剂量链激酶(S.K.)局部输注的结果并不更好,而在较短输注时间内给予更高剂量的S.K.或U.K.可提高溶解效果并降低出血并发症发生率。当传统的内科或外科技术被认为与高失败风险或并发症相关时,我们已将局部溶栓治疗用于威胁肢体的缺血病例。具体适应证为动脉粥样硬化性动脉血栓形成、Fogarty导管无效的远端或陈旧性栓塞以及移植物血栓形成导致的急性或亚急性缺血情况。伴有神经受累的严重急性缺血不是好的适应证。即使在病程长达一个月后,局部溶栓对动脉闭塞也可能成功。

相似文献

1
[Intra-arterial thrombolytic therapy of lower limb ischemia].
Bull Acad Natl Med. 1990 Feb;174(2):197-207; discussion 207-9.
10
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.
Ann Surg. 1994 Sep;220(3):251-66; discussion 266-8. doi: 10.1097/00000658-199409000-00003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验